drugset / Trial / NCT00214552
Evaluate the Effects on Asthma Control of Rabeprazole Given Twice Daily in Subjects With Asthma.
Phase 3
Completed
80 enrolled
Associated Scientists to Help Minimize Allergies
Eisai Inc. · collabJanssen Pharmaceuticals · collab
RandomizedParallel-groupDouble-blindPrevention
Summary
The hypothesis for this study is that potent anti-secretory therapy with high dose PPI improves asthma control regardless of either asthma severity or the presence of GERD symptoms.
Timeline
- Start
- 2002-09
- Primary completion
- 2005-03
- Completion
- 2005-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rabeprazole | Small molecule | — | — |